DSCR4 (Down syndrome critical region 4) is an orphan retrotransposon-derived de-novo originated protein coding gene present only in hominoids (humans and great apes). Despite being located on the medically critical genomic region and abundance of evidences indicating its functionality, the role of this gene in human cells was utterly unknown. Due to absence of any prior knowledge regarding the function of DSCR4, for the first time here we used a gene-overexpression approach to discover biological importance and cellular roles of this gene. Our analysis strongly indicates DSCR4 to be mainly involved in regulation of the interconnected biological pathways related to cell migration, coagulation and immune system. We also showed that the predicted biological functions are consistent with tissue-specific expression of DSCR4 in migratory immune system leukocyte cells and neural crest cells that shape facial morphology of human embryo. Immune system and neural crest cells are also shown to be affected in Down syndrome patients who suffer from the same type of DSCR4 misregulation as in our study which further support our findings.
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of leukemia. Mental retardation, characterized by certain behavioral and cognitive deficits is also common feature in DS individuals 3-5 . DS is caused by the inheritance of an extra copy of the chromosome 21 long arm (q arm). Since the completion of human genome project, it is known that this region span ~ 33.5 million base pairs (Mb) of DNA and contain ~300 genes 6 . So far mouse transgenic models have been the main tool for the analysis of gene-phenotype correlation in DS 7, 8 . Studies of trisomic mouse models containing an extra copy of mouse genome, orthologous to q arm of chromosome 21, implies upregulation of all trisomic genes by ~50% across multiple tissues 7, 8 . Although the underlying mechanism accounting for how the relatively small increment in transcription results in any of the commonly observed phenotypes in DS is yet unknown, the correspondence of shortest genomic region shared by DS individuals with the same DS characteristics has led to the hypothesis that a critical chromosomal region called Down Syndrome Critical Region (DSCR) contain a dosage-sensitive gene or set of genes misregulation of which are responsible for emergence of DS features 9 . The best-defined DSCR spans about ~5.4 million Mb ranging from a proximal boundary between DS21S17 and D21S55 to distal boundary between MX1 and BCEI 10 . This region harbor about 33 conserved genes between human and mouse 11 and have been associated with multiple DS characteristics such as craniofacial abnormalities, joint hyperlaxity and mental retardation 2 .
DS Studies using multiple transgenic mouse models in which DSCR orthologous region is overexpressed/ underexpressed, in particular chromosome 16 segmental trisomies such as Ts1Cje, Ts65Dn and Ts1Rhr and segmental monosomies including Ms1Rhr, have so far provided valuable information in constructing the phenotype map of DSCR 12 . However, investigations on functional annotation of orthologous genes located on DSCR revealed that, first, the mouse orthologous genes are actually dispersed within the genome and do not have the same synteny as human 13 and second, not all the genes present in human DSCR region do have orthologs in mouse which proves the inaccuracy of DS mouse models in simulating human Down syndrome condition in mouse.
Down Syndrome Critical Region 4 (DSCR4) is one of the novel de-novo originated protein coding genes on DSCR region which is present only in humans and great apes and lack orthologous counterpart in 4 non-hominine organisms including mice ( Fig. 1) 14 . This gene, also called as DSCRB 15 share a bidirectional promoter with DSCR8 gene and is positively and negatively regulated by multiple transcription factors [16] [17] [18] .
DSCR4 codes an experimentally verified 118 amino acids long protein 19 with strong potentials for forming protein secondary structure 14 , however, this protein shows no significant sign of homology to any know or putative protein domains 14, 15 . This lack of homology is expected due to the de novo origin of DSCR4 and considering the fact that majority of three coding exons of this gene is derived from retrotransposons 14 .
DSCR4 has been shown be a genetic marker for detection of Down Syndrome 20 and hence might act as one of the confounding factors in using mouse models to precisely simulate DS condition. However, no study has so far investigated the functionality and cellular interactions of DSCR4 inside human cells.
In this study, to understand the cellular roles and gene regulatory networks in which DSCR4 is involved, we overexpressed the wild type DSCR4 in human non-cancerous cells and measured the consequences on cell transcriptome by differential gene expression analysis. It has been shown that chromosome 21 transcripts are increased proportionally to the gene dosage, i.e. 50% greater than normal in DS cells 7 . Therefore, to simulate the DS condition, we used overexpression as a means for gene perturbation. Through functional profiling, we investigated the biological processes affected by perturbation of DSCR4 to unravel the role and position of DSCR4 in cellular pathways and its contribution to the etiology of Down syndrome and unique characteristics of hominoids 21 . Our analysis provides evidences for the functionality of DSCR4 in regulation of cell migration and immune system which are also the biological pathways affected in Down syndrome patients.
Materials and methods:
Cell culture. cDNA being the only difference between PTCN-DSCR4 and PTCN-control, we sought to minimize the confounding elements in our differential gene expression analysis.
Kill curve assay
The first critical step for generating stably transfected cells is determining the optimal concentration of selection reagent for selecting stable cell colonies. The purpose of kill curve assay is to determine the minimum antibiotic concentration needed to kill all the cells over the course of one week. Since the optimal concentration is cell type dependent, we performed this assay for HS27A cells using cell counting kit-8 (SIGMA). The HS27A cells were treated with G418 (SIGMA) in concentration gradient between 0 (negative control) to 1500 μ g/ml. The number of cells in each well were counted after a week and the optimum concentration of G418 for treatment of HS27A cell was determined as 1400 μ g/ml.
DNA transfection and stable cell line selection.
For transfection of HS27A cells with PTCN-DSCR4 plasmid, first the optimized concentration of OMNIfect™ transfection reagent was determined using a concentration gradient of OMNIfect and a 6 pcDNA3 vector containing GFP marker. In the next step, using the optimized concentration of OMNIfect (2 μ l/ml), the PTCN-DSCR4 and PTCN-control vectors were transfected into HS27A cells. The single cell colonies successfully transfected with DSCR4 were selected by incubation with RPMI-1640 containing 10% FBS and 1400 μ g/ml of G418 (Geneticin) over approximately 21 days.
Acquisition, preprocessing of microarray data and differential expression analysis Total RNA was extracted from three PTCN-DSCR4 transfected and three PTCN-control transfected HS27A samples along with one normal HS27A sample using PureLink® RNA Mini Kit (Invitrogen) and
RNA quality was assessed and confirmed using Agilent 2100 Bioanalyzer (Agilent Technologies). The isolated RNA was then carried through the Agilent preparation protocol and each sample was hybridized to one SurePrint G3 Human 8x60K v3 GeneChip (Agilent Technologies). Raw data were processed and analyzed using the GeneSpring GX software along with RobiNA package 22 . Quality assessment procedure was conducted by normalized expression value correlation analysis between the three samples groups (See supplementary Fig. S2 , Supplementary Material online). The normalized expression values (log base 2) for each chip were calculated using quantile normalization after background correction by RMA method 23 which has been proven to measure expression levels reliably. The gene expression matrix was filtered to exclude probe sets which are either not positive or significant, not uniform, not above background or population outliers. After all, saturated probe sets defined as "Class P" by GeneSpring GX software in PTCN-DSCR4 transfected HS27A samples with at least two-fold change in expression comparing with PTCN-control transfected HS27A samples were determined and used for further gene set enrichment analysis. 7 Confirmation of DSCR4 gene perturbation using qPCR Quantitative real-time PCR was conducted by synthesizing cDNA from 1mg DNA-free RNA using random 6-mer primers and PrimeScript First Strand cDNA Synthesis kit (Takara). Quantitative PCR was performed using CFX96 Touch™ Real-Time PCR Detection System. Expression of DSCR4 and GAPDH housekeeping genes were measured using SYBR Green-based gene expression assay (Applied Biosystems).
The primers for QPCR analysis were designed to amplify intron-exon boundaries so to avoid amplification of any potential DNA contamination. GAPDH housekeeping gene was used as endogenous control for the normalization. As expected, no significant difference between the cycle threshold (ct) values was observed for GAPDH across all the samples. Melt curve analysis also confirmed strictly specific amplifications in Results:
Functional analysis
There are multiple biological evidences indicating functionality of the de novo originated protein coding gene, DSCR4 gene such as possessing epigenomic marks for active regulatory region within the promoter, potential secondary structure in DSCR4-coded protein, harboring fetal epigenomic marker for detection of Down syndrome and being the binding site for multiple transcription factors 14 . To verify the functionality of DCSR4 using an evolutionary approach, we also performed Derived Allele Frequency (DAF) analysis. DAF analysis using 1000 genome project data revealed DSCR4 protein coding sequences to have higher rate of polymorphisms with low-frequency derived alleles compared with DSCR4 intronic sequences ( Fig. 2A ). DSCR4 has not been under selection constraint between chimpanzee and human (Dn/Ds ratio = 0.996) 14 , however, results of DAF analysis prove that DSCR4 CDSs are under purifying selection in human populations.
Intrinsic structural disorder (ISD) is the degree to which a given peptide folds as a stable threedimensional protein i.e. ordered protein versus a rather flexible and unstructured entity i.e. disordered.
Natural protein sequences are proved to be more intrinsically disordered than translated random sequences 27, 28 therefore ISD can be used as a criterion to distinguish functional genes from random ORFs erroneously identified as novel genes. ISD analysis of DSCR4 using IUPred 29 indeed revealed that the protein coded by this gene has significantly higher degree of ISD compared with its proximate but older protein coding gene, DSCR8 and conserved housekeeping genes such as GAPDH and ACTB (Fig. 2B ). Translated DSCR4 intron on the other hand has very low ISD score. 
Predicting DSCR4 functions by Gene Ontology analysis
After identification of DSCR4-overexpression-mediated differentially expressed genes, we performed gene ontology analysis to identify the interconnected cellular pathways enriched in DEGs.
Functional annotation tools were used to arrange genes in associated categories based on associated gene ontology (GO) terms and participation in biological pathways.
The six GO terms significantly enriched in downregulated DEGs represent interconnected pathways in gene regulatory network of human cells (Fig. 3A and 3B ). Four out of the six enriched pathways are directly involved in the regulation of movement, migration and motility of cell or cells compartments.
Regulation of cell migration is defined as any process that modulates the frequency, rate or extent of cell migration and regulation of cellular component movement is defined as any process that modulates the frequency, rate or extent of the movement of a cellular component 30 equilibrium of a tissue such as in bone remodeling 30 . The remodeling processes are critical during development, wound repair and metastatic invasion and are driven by coordinated migration of cells through three-dimensional (3D) extracellular matrix 31 . The other two pathways in which downregulated DEGs are enriched are also indirectly involved in regulation of cell migration. The pathway, Positive regulation of catenin import into nucleus, is defined as any process that increases the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus 30 . The import of β -catenin from cytoplasm to nucleus with assistance of Wnt protein, leads to activation a signaling pathway named Wnt/βcatenin signaling 32 . It has been shown that Wnt/β-catenin signaling pathway is involved in cell migration of breast cancer cells and metastasis 32, 33 . Negative regulation of JUN kinase is the other enriched pathway in downregulated DEGs and is described as any process that stops, prevents, or reduces the frequency, rate or extent of JUN kinase activity. JUN N-terminal Kinases are a group of kinase enzymes that bind and phosphorylates the c-JUN proteins. C-jun is a proto-oncogene and is the homolog of the viral oncoprotein vjun 34 . In breast cancer cells, c-jun is known to play key role in migration and invasion of mammary epithelial cells 35 . In summary, the enriched pathways and processes within the downregulated DEGs mediated by DSCR4-overexpression consistently indicate the likely role of DSCR4 in regulation of cell migration.
The upregulated genes mediated by DSCR4 overexpression are enriched mainly in regulation of coagulation and hemostasis processes along with maintenance of apical/basal cell polarity ( Fig. 3 C and 3D ).
Regulation of hemostasis and coagulation are respectively defined as the processes leading to stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ and the processes that modulates the frequency, rate or extent of coagulation. Hemostasis and coagulation processes are critical for the function of blood and innate immune systems 36, 37 . On the other hand, the enriched genes involved in maintenance of apical/basal cell polar, including wnt11 and ankyrin1, were found to be directly involved in regulation of cell migration which is the biological function also enriched in downregulated DEGs. Ankyrin1 which is a cytoskeleton adaptor protein has been shown to be affected by p53 and alter cell migration 38 and by interacting with silberblick, Wnt11 is found to be involved in controlling cell migration and morphogenesis in zebra fish 39 . also with processes of cell migration, adhesion and proliferation (Fig. 4 ). In summary, these results indicate that all the affected pathways by DSCR4 gene perturbation are closely connected and are mainly involved in the processes of cell migration, immune system and coagulation.
Discussion:
DSCR4 is an orphan gene present only in Humans and Great apes, evolution of which has occurred in multiple steps over the past 100 million years mainly as a result of the function of retrotransposons (Fig.   1 ). Young de-novo originated genes have been known with a tendency to be small in size with relatively low expression values and weak conservation signals which also hold for DSCR4 and raise doubts about the functionality of this young de-novo originated experimentally-verified protein coding gene 18 ; recent investigation of intrinsic structural disorder (ISD) however support preadaptation hypothesis of de-novo gene evolution indicating that young genes show extreme levels of gene-like traits and rejects the continuum view of de novo gene birth which suggests a series of intermediate stages, or 'proto-genes', between noncoding DNA sequences and a fully functional gene 44 . Same results were also found in ISD analysis of DSCR4 ( Fig. 2B ) which is consistent with the results of derived allele frequency analysis ( Fig. 2A) and previous findings by Saber et al. 14 and further support the functionality of DSCR4.
The results of our gene regulatory network and gene ontology analysis of DSCR4-overexpressionmediated DEGs along with pathway enrichment investigations consistently indicate the likely role of DSCR4 in cell migration, coagulation and immune system. If these predictions are correct, we would expect DSCR4 to be expressed mainly in cells with migratory characteristics. We investigated this hypothesis by quantifying the expression of DSCR4 across all human cells transcriptome data available in Roadmap epigenome project 45 and YuGene database 46 . Only a small portion of highly specialized cells is able to actively migrate within human body which include leukocytes, stem cells and immune system cells 47 . In line with our predictions, Roadmap data analysis revealed that DSCR4 has significant expression only in K562 cells (Fig. 5 ). K562 is human immortalized myelogenous leukemia cell with erythroleukemia type. 1 3 Consistently, analysis of YuGene database also revealed that monocytes which are a type of white blood cells or leukocytes are the cells with highest expression level of DSCR4 (See supplementary Fig. S6 , at DSCR region where DSCR4 is located, leading to an average 50% overexpression of genes located on this region. Acute leukemia has been associated with Down Syndrome 10-20 fold higher than general population and this disorder is known as one the most leukemia-predisposing syndrome 50, 51 . Additionally, DSCR4 has been shown to be under copy number amplification in leukemia cells (See Supplementary Fig. S7 , Supplementary Material online) 52 . Leukocytes are top human cells expressing DSCR4 to significant levels ( Fig. 5 and Supplementary Fig. S6 , Supplementary Material online) with active migratory characteristics and prominent role in coagulation process 53 which are the biological functions enriched in DSCR4- 1 4 overexpression-mediated DEGs. Another main characteristic of Down Syndrome patients is immune deficiency, especially at innate immune system 54 . This symptom of Down syndrome patients is consistent with our findings as innate immune system is enriched with genes affected by DSCR4 overexpression ( Fig. 4 and Supplementary Fig. S5, Supplementary Material online) . In addition, multiple immune system cells including monocytes (leukocytes), T-cells and dendritic (DS) cells were shown to be notably expressing DSCR4 gene (See Supplementary Fig. S6 , Supplementary Material online) which indicate active role of DSCR4 in immune system cells. Dysmorphology of facial characteristics is yet another main feature of Down Syndrome patients which can be explained, at least in part, by our findings that DSCR4 is involved in regulation of cell migration and that neural crest cells (NCC) do have notable expression of DSCR4 ( Fig. 5 and Supplementary Fig. S6 , Supplementary Material online). Cell migration is essential for the function of NCCs which form the facial characteristics of embryo, hence, imbalanced DSCR4 expression can affect the migratory behavior of NCCs which in turn could affect facial morphology of Down syndrome patients.
DSCR4 is an orphan retrotransposon-derived gene existing only in humans and great apes which although locating a medically critical region, its function was yet unexplored. Because there was no previous study on the functions of this gene, we were obliged to use a brute-force approach for identification of its functions that is a statistically challenging objective considering the moderate cellular effects of short and (B) Intrinsic structural disorder (ISD) characteristics of DSCR4. DSCR4 protein shows high degree of intrinsic structural disorder comparing to its proximate but older protein coding gene, DSCR8 and conserved old house keeping genes such as GAPDH and ACTB. ISD score of DCSR4 is also significantly higher than that of DSCR4 translated introns. 
